Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Palmitoyltransferase ZDHHC14 is a member of the DHHC (Asp-His-His-Cys) motif-containing palmitoyl acyltransferases, enzymes responsible for S-palmitoylation of proteins, a post-translational modification involving the addition of palmitate to cysteine residues. ZDHHC14 is distinguished by its unique C-terminal Type-I PDZ ligand (LSSV) and is highly expressed in the hippocampus, where it plays a critical role in palmitoylating and appropriately localizing key neuronal proteins such as PSD93 and Kv1-family potassium channels. Its activity is essential for normal voltage-gated potassium channel clustering at the axon initial segment and thus for regulating neuronal excitability. Loss of ZDHHC14 disrupts this process, affecting electrical properties of neurons. ZDHHC14’s function appears to be non-redundant, and it is intolerant to loss-of-function mutations in humans[1][3][5][4]. There are currently no approved drugs or chemical probes known to selectively target ZDHHC14, and none of its interacting drugs or safety concerns have been identified in clinical settings.
Not applicable (no approved drugs or tool compounds known to target ZDHHC14 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Palmitoyltransferase ZDHHC14 (ZDHHC14).